Denis Claude Roy

Title: Denis Claude Roy: Innovator in Immunologic Treatments

Introduction

Denis Claude Roy is a notable inventor based in Laval, Canada. He has made significant contributions to the field of immunology, particularly through his innovative approaches to treatment and prevention of various disorders.

Latest Patents

Denis Claude Roy holds a patent titled "The Use Of Dead Cell Material Obtained From Rhodamine-Based Photodynamic Therapy In The Treatment Or Prevention Of Immunologic Disorders, Infections And Cancers." This invention focuses on the use of photodynamic therapy (PDT)-treated cells in the preparation of vaccines aimed at immunoprotection or immunomodulation. The patent outlines a method where individual cells are treated with a photoactivatable molecule, which is activated by light of an appropriate wavelength. This activation leads to the prevention, protection, prophylaxis, or treatment of immunological disorders, infections, and cancers.

Career Highlights

Throughout his career, Denis Claude Roy has worked with esteemed institutions such as Université de Montréal and Hôpital Maisonneuve-Rosemont. His work in these organizations has allowed him to collaborate with other professionals in the field and contribute to groundbreaking research.

Collaborations

Denis has collaborated with notable colleagues, including Marc Vaillancourt and Luc Villeneuve. These partnerships have enriched his research and expanded the impact of his innovations.

Conclusion

Denis Claude Roy's work in immunology and his innovative patent demonstrate his commitment to advancing medical science. His contributions have the potential to significantly impact the treatment and prevention of immunologic disorders, infections, and cancers.